STELLARIS PHARMACEUTICALS ApS: Financial statements 2015
CVR: 34708215
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
STELLARIS PHARMACEUTICALS ApS (CVR 34708215) has filed annual accounts for 2015. In 2015, the company reported a net result of DKK -127,288 compared with DKK -384,376 the year before. Equity in the 2015 report amounted to DKK -457,474.
- Profit/Loss
- DKK -127,288
- Equity
- DKK -457,474
- Total Assets
- DKK 62,314
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | - | -127 t. | -457 t. | - |
| 2014 | - | - | -384 t. | -330 t. | - |
Official annual report
How creditworthy is STELLARIS PHARMACEUTICALS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2014. The net result was DKK -384,376.
About STELLARIS PHARMACEUTICALS ApS
STELLARIS PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Birgit Ter-Borch Gram Lilienfeldt Schjoldager. The company is owned by Ranoda Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -475,262 and a net result of DKK -594,882 compared with DKK -486,941 the year before. Equity in the 2025 report amounted to DKK -3,565,816.